1352925-68-8

Basic information

• Product Name: tert-butyl 4-((benzylaMino)Methyl)-4-hydroxypiperidine-1-carboxylate
• Synonyms: tert-butyl 4-((benzylaMino)Methyl)-4-hydroxypiperidine-1-carboxylate
• CAS NO: 1352925-68-8
• Molecular Formula: C₁₈H₂₈N₂O₃
• Molecular Weight: 320.42652
• Mol File: 1352925-68-8.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4-((benzylaMino)Methyl)-4-hydroxypiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-((benzylaMino)Methyl)-4-hydroxypiperidine-1-carboxylate(1352925-68-8)
• EPA Substance Registry System: tert-butyl 4-((benzylaMino)Methyl)-4-hydroxypiperidine-1-carboxylate(1352925-68-8)

Safety Data

• Hazardous Substances Data: 1352925-68-8(Hazardous Substances Data)

Usage

General Description

"Tert-butyl 4-((benzylamino)methyl)-4-hydroxypiperidine-1-carboxylate" is a chemical compound used in the pharmaceutical industry. It is an ester derivative of piperidine with a tert-butyl group and a benzylamino moiety. tert-butyl 4-((benzylaMino)Methyl)-4-hydroxypiperidine-1-carboxylate is a potential therapeutic agent for the treatment of various medical conditions, such as neurological disorders and pain management. Its unique structure and functional groups make it a promising candidate for drug development and research. Additionally, the combination of tert-butyl and benzylamino groups in the molecule provides certain pharmacokinetic and pharmacodynamic properties that are desirable for potential medication applications.

Upstream product

• 100-46-9 benzylamine 
• 147804-30-6 1-oxa-6-aza-spiro-[2.5]octane-6-caboxylic acid tert-butyl ester 

Downstream Products

• 1400642-83-2 tert-butyl 10-benzyl-8-vinyl-7-oxa-3,10-diazaspiro[5.5]undecane-3-carboxylate 
• 1400643-12-0 tert-butyl 4-[[benzyl-[2-oxo-2-(2-pyridyl)ethyl]amino]methyl]-4-hydroxy-piperidine-1-carboxylate 
• 1400643-14-2 tert-butyl 10-(2-pyridyl)-11-oxa-3,8-diazaspiro[5.5]undecane-3-carboxylate 
• 1400642-84-3 tert-butyl 8-benzyl-10-(1,2-dihydroxyethyl)-11-oxa-3,8-diazaspiro[5.5]undecane-3-carboxylate 
• 1400642-86-5 9-tert-butyl 2-methyl 4-benzyl-1-oxa-4,9-diazaspiro[5.5]undecane-2,9-dicarboxylate 
• 1400642-85-4 C₂₁H₃₀N₂O₄ 

Relevant articles and documents

HIV PROTEASE INHIBITORS

The present invention is directed to 2,6-morpholine derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein Z1, Z2, V1, V2, V3, R6, R6A, and X are defined herein. The invention also relates to methods of using the 2,6-morpholine derivatives of the invention for the inhibition of HV protease, the inhibition of HV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

AMIDE DERIVATIVES OF 1-OXA-4,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN

The present invention relates to compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opioid receptor and more particularly to diazaspiro undecane compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain. (formula 1) wherein Y is (formula 2) or (formula 3) ? n is 1 or 2; ? q is 1, 2, 3, 4, 5 or 6; ? X is a bond, -C(O)O-, -C(0)NR 8-, -C(O)-, -0- or -C(R 4R 4.)-; ? R 1is C(0)R 5or S(O) 2R 5.